Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 3/20 | 0.36 |
| ▸ | CYCS | P99999 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16923713 | 1.00 | TOP1 (0.36) | TOP1CYCSMEN1KMT2AABCG2 | |
| SCHEMBL16923657 | 0.77 | MEN1 (0.53) | TOP1CYCSMEN1KMT2A | |
| SCHEMBL26401166 | 0.75 | JAK3 (0.47) | TOP1CYCSMEN1KMT2A | |
| SCHEMBL16920382 | 0.74 | MEN1 (0.50) | TOP1CYCSMEN1KMT2A | |
| SCHEMBL16923663 | 0.73 | TOP1 (0.52) | TOP1CYCSMEN1KMT2AENPP2 | |
| SCHEMBL17934752 | 0.71 | TOP1 (0.60) | TOP1CYCSABCG2ENPP2TERT | |
| SCHEMBL16923752 | 0.71 | TOP1 (0.46) | TOP1CYCSABCG2ENPP2TERT | |
| SCHEMBL19888947 | 0.70 | TOP1 (0.56) | TOP1CYCSABCG2ENPP2TERT | |
| SCHEMBL16920383 | 0.70 | TOP1 (0.44) | TOP1CYCSMEN1KMT2A | |
| SCHEMBL4413776 | 0.69 | TOP1 (0.53) | TOP1CYCSABCG2ENPP2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150202293-A1 | CONJUGATE OF A PHOTOSENSITISER AND CHITOSAN AND USES THEREOF | PCI BIOTECH AS (NO) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202293-A1 | CONJUGATE OF A PHOTOSENSITISER AND CHITOSAN AND USES THEREOF | TLR3, CD47, TLR9 | TOP1 2741/4885CYCS 3103/4885MEN1 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.